[
{"id":"1","list":"Pre Market Movers","symbol": "ADXS","name": "Advaxis Inc","price": 9,"dollarChange": 0.250000,"percentChange": 2.857143,"time":4.0,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/ADXS-1d.php","oneMonth": "http://automatedinvestmentresearch.com/ADXS-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/ADXS-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/ADXS-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/ADXS-1yr.php","open": 8.66,"high": 8.92,"low":8.42,"volume": 575067,"avgVol": 717505.883333,"sharesShort": 8696343,"shortPercent": 21.674726,"marketCap": 352672757,"float": 40122043,"headlines":{"data":[{"title":"Advaxis to Present at the 2017 Barclays Global Healthcare Conference","publication_date":"2017-03-13 12:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-present-2017-barclays-global-120000667.html","summary":"[GlobeNewswire] - PRINCETON, N.J., March 13, 2017-- Advaxis, Inc., a biotechnology company developing cancer immunotherapies, today announced that Sara Bonstein, Chief Financial Officer of Advaxis, will present a corporate ..."},{"title":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : March 10, 2017","publication_date":"2017-03-10 12:48:22 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-breached-its-50-day-moving-average-in-a-bullish-manner-adxs-us-march-10-2017/","summary":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : March 10, 2017"},{"title":"Advaxis Appoints Al Blunt, M.D., as its Vice President of Medical","publication_date":"2017-03-07 13:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-appoints-al-blunt-m-130000607.html","summary":"[GlobeNewswire] - PRINCETON, N.J., March 07, 2017-- Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced Al Blunt, M.D., has joined the company as Vice President of Medical. ..."},{"title":"Advaxis stock jumps 10% after FDA okays clinical trials for Amgen-partnered cancer drug","publication_date":"2017-03-06 13:41:20 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=500B25B5-4384-448A-9A34-03F583E1EA08&siteid=yhoof2","summary":"Advaxis stock jumps 10% after FDA okays clinical trials for Amgen-partnered cancer drug"},{"title":"6:01 am Advaxis announces FDA acceptance of IND for personalized neoepitope immunotherapy, ADXS-NEO","publication_date":"2017-03-06 11:01:00 +0000","url":"http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#adxs","summary":"6:01 am Advaxis announces FDA acceptance of IND for personalized neoepitope immunotherapy, ADXS-NEO"},{"title":"Advaxis Announces FDA Acceptance of IND for Groundbreaking Personalized Neoepitope Immunotherapy, ADXS-NEO","publication_date":"2017-03-06 11:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-announces-fda-acceptance-ind-110000608.html","summary":"[GlobeNewswire] - PRINCETON, N.J., March 06, 2017-- Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced that the U.S. Food and Drug Administration has indicated the Investigational ..."},{"title":"These 5 Stocks Under $10 Could Explode Up Soon","publication_date":"2017-03-02 18:21:00 +0000","url":"https://www.thestreet.com/story/14024188/1/these-5-stocks-under-10-could-explode-up-soon.html?puc=yahoo&cm_ven=YAHOO","summary":"These 5 Stocks Under $10 Could Explode Up Soon"},{"title":"Advaxis to Host Research Reception at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer","publication_date":"2017-03-02 13:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-host-research-reception-society-130000728.html","summary":"[GlobeNewswire] - PRINCETON, N.J., March 02, 2017-- Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, will host a Research Reception during the Society of Gynecologic Oncology Annual ..."},{"title":"Advaxis Inks Cancer Drug Deal with Sellas","publication_date":"2017-02-28 15:31:00 +0000","url":"http://www.investopedia.com/news/advaxis-inks-cancer-drug-deal-sellas-adxs/?partner=YahooSA","summary":"Advaxis Inks Cancer Drug Deal with Sellas"},{"title":"Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-Targeting Immunotherapy","publication_date":"2017-02-27 13:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-sellas-announce-licensing-agreement-130000474.html","summary":"[GlobeNewswire] - PRINCETON, N.J., and HAMILTON, Bermuda, Feb. 27, 2017-- Advaxis, Inc. and SELLAS Life Sciences Group, both late-stage biopharmaceutical companies focused on developing cancer immunotherapies, today announced ..."},{"title":"Advaxis Announces First Patient Dosed in Global Phase 3 AIM2CERV Trial for High-risk, Locally Advanced Cervical Cancer","publication_date":"2017-02-06 13:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-announces-first-patient-dosed-130000227.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Feb. 06, 2017-- Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, announced that the first patient has been enrolled and dosed in its AIM2CERV trial, ..."},{"title":"GOG-0265 Study in Metastatic Cervical Cancer Selected for Late-Breaking Data Presentation at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer","publication_date":"2017-01-30 13:30:00 +0000","url":"http://finance.yahoo.com/news/gog-0265-study-metastatic-cervical-133000841.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Jan. 30, 2017-- Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced that an abstract on data from the company’ s Phase 2 GOG-0265 trial ..."},{"title":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : January 26, 2017","publication_date":"2017-01-26 12:46:48 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-breached-its-50-day-moving-average-in-a-bullish-manner-adxs-us-january-26-2017/","summary":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : January 26, 2017"},{"title":"New Published Research Reveals that Cervical Cancer Mortality Rates May Be Significantly Higher in the United States than Previously Reported","publication_date":"2017-01-25 13:00:00 +0000","url":"http://finance.yahoo.com/news/published-research-reveals-cervical-cancer-130000469.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Jan. 25, 2017-- Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today pointed to research published in the journal Cancer which underscores the ..."},{"title":"Advaxis, Inc. – Value Analysis (NASDAQ:ADXS) : January 13, 2017","publication_date":"2017-01-13 15:43:44 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-value-analysis-nasdaqadxs-january-13-2017/","summary":"Advaxis, Inc. – Value Analysis (NASDAQ:ADXS) : January 13, 2017"},{"title":"ADVAXIS, INC. Financials","publication_date":"2017-01-12 18:04:05 +0000","url":"http://finance.yahoo.com/q/is?s=adxs","summary":"ADVAXIS, INC. Financials"},{"title":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : January 12, 2017","publication_date":"2017-01-12 12:19:43 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-breached-its-50-day-moving-average-in-a-bullish-manner-adxs-us-january-12-2017/","summary":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : January 12, 2017"},{"title":"ADVAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits","publication_date":"2017-01-09 13:31:28 +0000","url":"http://biz.yahoo.com/e/170109/adxs8-k.html","summary":"ADVAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits"},{"title":"Advaxis Provides 2017 Business Outlook","publication_date":"2017-01-09 13:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-provides-2017-business-outlook-130000129.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Jan. 09, 2017-- Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today issued its 2017 business outlook to provide an overview of anticipated events ..."},{"title":"ADVAXIS, INC. Files SEC form 10-K, Annual Report","publication_date":"2017-01-09 11:39:13 +0000","url":"http://biz.yahoo.com/e/170109/adxs10-k.html","summary":"ADVAXIS, INC. Files SEC form 10-K, Annual Report"},{"title":"ADVAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-12-15 21:31:42 +0000","url":"http://biz.yahoo.com/e/161215/adxs8-k.html","summary":"ADVAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"Discussion on Advaxis’ ADXS-NEO, ADXS-HOT Programs Held During the International Congress on Immunotherapies in Cancer","publication_date":"2016-12-12 13:15:00 +0000","url":"http://finance.yahoo.com/news/discussion-advaxis-adxs-neo-adxs-131500062.html","summary":"[GlobeNewswire] - Presentation detailed Advaxis’ bacterial vector system, new preclinical program in hotspots. PRINCETON, N.J., Dec. 12, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, ..."},{"title":"Advaxis to Present Data at ImVacS-Immunization and Vaccine Summit on Use of Detoxified Listeriolysin O (dtLLO) as an Effective Adjuvant in Vaccine Formulations","publication_date":"2016-12-07 13:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-present-data-imvacs-immunization-130000991.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Dec. 07, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that preclinical data on the potential use of detoxified Listeriolysin ..."},{"title":"How Advaxis, Inc. (ADXS) Stacks Up Against Its Peers","publication_date":"2016-12-04 20:42:20 +0000","url":"http://www.insidermonkey.com/blog/how-advaxis-inc-adxs-stacks-up-against-its-peers-498315/","summary":"How Advaxis, Inc. (ADXS) Stacks Up Against Its Peers"},{"title":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : November 22, 2016","publication_date":"2016-11-22 12:15:21 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-breached-its-50-day-moving-average-in-a-bullish-manner-adxs-us-november-22-2016/","summary":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : November 22, 2016"},{"title":"INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc.","publication_date":"2016-11-18 16:35:00 +0000","url":"http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-163500961.html","summary":"[Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Advaxis, Inc. concerning possible breaches of fiduciary duty by the board of directors of the company."},{"title":"Advaxis to Present at the Jefferies 2016 London Healthcare Conference","publication_date":"2016-11-15 13:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-present-jefferies-2016-london-130000567.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Nov. 15, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel O’ Connor, president and chief executive officer of ..."},{"title":"ETF’s with exposure to Advaxis, Inc. : November 11, 2016","publication_date":"2016-11-11 17:20:57 +0000","url":"http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-advaxis-inc-november-11-2016/","summary":"ETF’s with exposure to Advaxis, Inc. : November 11, 2016"},{"title":"Advaxis to Present Phase 1 Combination Data and New Preclinical Data Using AXAL at Upcoming Society for Immunotherapy of Cancer (SITC) 2016 Annual Meeting","publication_date":"2016-11-11 12:30:00 +0000","url":"http://finance.yahoo.com/news/advaxis-present-phase-1-combination-123000192.html","summary":"[GlobeNewswire] - Phase 1 AXAL and durvalumab combination trial shows safety and tolerability in cervical and HPV+ head and neck cancer Preclinical data demonstrate synergistic antitumor effects of AXAL combined with a ..."},{"title":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : November 10, 2016","publication_date":"2016-11-10 13:25:33 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-breached-its-50-day-moving-average-in-a-bullish-manner-adxs-us-november-10-2016/","summary":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : November 10, 2016"},{"title":"Noteworthy Tuesday Option Activity: GOOG, NXST, ADXS","publication_date":"2016-11-01 21:15:41 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uYm-3UhDIU8/noteworthy-tuesday-option-activity-goog-nxst-adxs-cm702055","summary":"Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Alphabet Inc Symbol GOOG where a total volume of 16 772 contracts has been traded thus far today a contract volume which is representative of approximately 1 7"},{"title":"Lifshitz & Miller Law Firm Announces Investigation of Advaxis, Inc., Banc of California, Inc., Biogen Inc., Franklin Resources, Inc., Juniper Pharmaceuticals, Inc., Opus Bank, Taro Pharmaceutical Industries Ltd., and Tyson Foods, Inc.","publication_date":"2016-10-28 17:15:00 +0000","url":"http://finance.yahoo.com/news/lifshitz-miller-law-firm-announces-171500113.html","summary":"[PR Newswire] - NEW YORK, Oct. 28, 2016 /PRNewswire/ -- Advaxis, Inc. (ADXS) Lifshitz & Miller announces investigation on behalf of ADXS investors. The investigation concerns whether over 1.5 million stock options were ..."},{"title":"Advaxis Cervical Cancer Drug Makes Progress (ADXS)","publication_date":"2016-10-27 18:28:00 +0000","url":"http://www.investopedia.com/news/advaxis-updates-cervical-cancer-drug-study-adxs/?partner=YahooSA","summary":"Advaxis Cervical Cancer Drug Makes Progress (ADXS)"},{"title":"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc. - ADXS","publication_date":"2016-10-27 18:03:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-180300369.html","summary":"[PR Newswire] - NEW YORK, Oct. 27, 2016 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of Advaxis, Inc. (NASDAQ: ADXS) concerning possible breaches of fiduciary duty by the board of directors ..."},{"title":"Notable Monday Option Activity: IIVI, ADXS, WHR","publication_date":"2016-10-24 21:24:18 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D_abS5lwq58/notable-monday-option-activity-iivi-adxs-whr-cm697443","summary":"Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in II VI Inc Symbol IIVI where a total volume of 4 313 contracts has been traded thus far today a contract volume which is representative of approximately 431 300"},{"title":"ADVAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits","publication_date":"2016-10-24 16:01:07 +0000","url":"http://biz.yahoo.com/e/161024/adxs8-k.html","summary":"ADVAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits"},{"title":"Advaxis stock drops as much as 14% after company releases data from trial that was halted last year","publication_date":"2016-10-24 12:28:23 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=0549B8DA-F579-43E3-988E-0ADD5FB76572&siteid=yhoof2","summary":"Advaxis stock drops as much as 14% after company releases data from trial that was halted last year"},{"title":"Advaxis Announces GOG-0265 12-month Overall Survival Rate of 37.5% in Stage 2","publication_date":"2016-10-24 12:11:02 +0000","url":"http://www.publicnow.com/view/3AD30AEF120D5F51F2A807B32DAFE1B455B39885","summary":"[at noodls] - Data in 50 patients with recurrent metastatic carcinoma of the cervix demonstrates a 52% increase in 12-month overall survival rate PRINCETON, N.J., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), ..."},{"title":"Advaxis Reports 37.5 Percent 12-month Overall Survival Rate For GOG-0265 Trial","publication_date":"2016-10-24 09:45:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GyyMDeiSjxs/advaxis-reports-375-percent-12month-overall-survival-rate-for-gog0265-trial-20161024-00557","summary":"Advaxis Reports 37.5 Percent 12-month Overall Survival Rate For GOG-0265 Trial"},{"title":"Advaxis Cervical Cancer Study Continues (ADXS)","publication_date":"2016-10-21 17:33:00 +0000","url":"http://www.investopedia.com/news/advaxis-opens-phase-3-cervical-cancer-trial-adxs/?partner=YahooSA","summary":"Advaxis Cervical Cancer Study Continues (ADXS)"},{"title":"Advaxis Phase 1/2 Cancer Trial Proceeds (ADXS)","publication_date":"2016-10-21 16:42:00 +0000","url":"http://www.investopedia.com/news/advaxis-prostate-cancer-study-moves-forward-adxs/?partner=YahooSA","summary":"Advaxis Phase 1/2 Cancer Trial Proceeds (ADXS)"},{"title":"Advaxis Initiates Combination Portion of Phase 1/2 Study with Merck","publication_date":"2016-10-20 11:48:07 +0000","url":"http://www.publicnow.com/view/4EC085044EF287DA3687FE6EE41DF3C720F4271E","summary":"[at noodls] - KEYNOTE-046 study to evaluate KEYTRUDA® in combination with ADXS-PSA Advaxis begins screening patients for Phase 3 AIM2CERV study in cervical cancer PRINCETON, N.J., Oct. 20, 2016 (GLOBE NEWSWIRE) -- Advaxis, ..."},{"title":"Advaxis Cleared for $2.7 Million Tax Credit (ADXS)","publication_date":"2016-10-13 17:48:00 +0000","url":"http://www.investopedia.com/news/advaxis-get-27-million-nol-tax-credit-adxs/?partner=YahooSA","summary":"Advaxis Cleared for $2.7 Million Tax Credit (ADXS)"},{"title":"Advaxis to Receive $2.5M through the New Jersey Economic Development Authority NOL Program","publication_date":"2016-10-13 12:10:03 +0000","url":"http://www.publicnow.com/view/96B5C8A3604084F8E1D7B072F8F818D5E4EF6FE9","summary":"[at noodls] - PRINCETON, N.J., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, has received preliminary approval for a $2.7 million ..."},{"title":"Advaxis Research Reception at SITC 2016 to Review Recent AXAL Highlights and the AXAL-Durvalumab Combination Poster","publication_date":"2016-10-11 12:19:04 +0000","url":"http://www.publicnow.com/view/7D2FC812B1C2D99CFE6B5051625EF4F77AC3F20C","summary":"[at noodls] - Reception to also feature update on ADXS-NEO: Personalizing Immunotherapy PRINCETON, N.J., Oct. 11, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing ..."},{"title":"INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc.","publication_date":"2016-10-10 21:40:00 +0000","url":"http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-214000977.html","summary":"[Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Advaxis, Inc. concerning possible breaches of fiduciary duty by the board of directors of the company."},{"title":"Advaxis CSO Invited to Speak at Immune Profiling World Congress","publication_date":"2016-10-06 12:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-cso-invited-speak-immune-120000872.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Oct. 06, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that Robert Petit, Ph.D., executive vice president and chief scientific ..."},{"title":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : October 5, 2016","publication_date":"2016-10-05 12:11:08 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-breached-its-50-day-moving-average-in-a-bullish-manner-adxs-us-october-5-2016/","summary":"Advaxis, Inc. breached its 50 day moving average in a Bullish Manner : ADXS-US : October 5, 2016"},{"title":"ADVAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers","publication_date":"2016-10-03 20:39:10 +0000","url":"http://biz.yahoo.com/e/161003/adxs8-k.html","summary":"ADVAXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers"},{"title":"Advaxis Appoints Christopher Duke as Chief Operating Officer","publication_date":"2016-10-03 12:26:07 +0000","url":"http://www.publicnow.com/view/3455E5D08EBC81627119658E0D00C71C9AC7F493","summary":"[at noodls] - Greg Mayes Becomes Company's First Chief Business Officer PRINCETON, N.J., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, ..."},{"title":"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of Advaxis, Inc. - ADXS","publication_date":"2016-09-28 15:10:00 +0000","url":"http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-151000439.html","summary":"[Accesswire] - NEW YORK, NY / ACCESSWIRE / September 28, 2016 / Levi & Korsinsky announces it has commenced an investigation of Advaxis, Inc. (NASDAQ: ADXS) concerning possible breaches of fiduciary duty by the board ..."},{"title":"Advaxis’ Lm Technology Immunotherapies to be Showcased in Three Poster Presentations at SITC Annual Meeting","publication_date":"2016-09-26 19:45:00 +0000","url":"http://finance.yahoo.com/news/advaxis-lm-technology-immunotherapies-showcased-194500739.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Sept. 26, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced three poster presentations have been accepted by the Society for ..."},{"title":"Advaxis to Present at the Aegis Annual Growth Conference","publication_date":"2016-09-19 20:30:00 +0000","url":"http://finance.yahoo.com/news/advaxis-present-aegis-annual-growth-203000082.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Sept. 19, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that Robert Petit, Ph.D., executive vice president and chief scientific ..."},{"title":"Advaxis, Inc. – Value Analysis (NASDAQ:ADXS) : September 13, 2016","publication_date":"2016-09-13 15:15:42 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-value-analysis-nasdaqadxs-september-13-2016/","summary":"Advaxis, Inc. – Value Analysis (NASDAQ:ADXS) : September 13, 2016"},{"title":"Advaxis, Inc. breached its 50 day moving average in a Bearish Manner : ADXS-US : September 12, 2016","publication_date":"2016-09-12 13:21:22 +0000","url":"http://www.capitalcube.com/blog/index.php/advaxis-inc-breached-its-50-day-moving-average-in-a-bearish-manner-adxs-us-september-12-2016/","summary":"Advaxis, Inc. breached its 50 day moving average in a Bearish Manner : ADXS-US : September 12, 2016"},{"title":"Advaxis Unveils State-of-the-art Manufacturing Facility, Laboratory to Produce and Develop Novel Immuno-Oncology Therapeutics","publication_date":"2016-09-12 12:18:08 +0000","url":"http://www.publicnow.com/view/D5E88DBFDA73051E512A26801B1A14B2D63D6A3F","summary":"[at noodls] - NJ Gov. Christie cuts ribbon, commends Advaxis milestone PRINCETON, N.J., Sept. 12, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, ..."},{"title":"N.J. Gov. Christie to Attend Advaxis Ribbon Cutting for New Manufacturing/Laboratory Facility in Princeton","publication_date":"2016-09-08 18:39:02 +0000","url":"http://www.publicnow.com/view/523E571456A29898F11568335CF2A0D1EE79BD3C","summary":"[at noodls] - MEDIA ADVISORY, Sept. 08, 2016 (GLOBE NEWSWIRE) -- WHAT: Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, will unveil its new state-of-the-art manufacturing ..."},{"title":"ADVAXIS, INC. Files SEC form 10-Q, Quarterly Report","publication_date":"2016-09-08 10:05:25 +0000","url":"http://biz.yahoo.com/e/160908/adxs10-q.html","summary":"ADVAXIS, INC. Files SEC form 10-Q, Quarterly Report"},{"title":"Advaxis to Present at Rodman & Renshaw 18th Annual Global Investment Conference","publication_date":"2016-09-06 12:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-present-rodman-renshaw-18th-120000323.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Sept. 06, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O’ Connor, president and chief executive officer ..."},{"title":"ADXS: Multiple Progresses Have Been Made","publication_date":"2016-08-25 19:30:00 +0000","url":"http://finance.yahoo.com/news/adxs-multiple-progresses-made-193000424.html","summary":"ADXS: Multiple Progresses Have Been Made"},{"title":"ADVAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits","publication_date":"2016-08-23 21:11:35 +0000","url":"http://biz.yahoo.com/e/160823/adxs8-k.html","summary":"ADVAXIS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits"},{"title":"4 Biotechs Breaking Out With Strong Momentum","publication_date":"2016-08-23 15:36:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H4yGSRaME3M/4-biotechs-breaking-out-with-strong-momentum-cm669025","summary":"By Harry Boxer Here are four biotech stocks with strong technical momentum. Advaxis, Inc. ( ADXS ) broke out of a 5-month coiling consolidation earlier this month, more than doubling on news of an immunotherapy agreement with Amgen, and now is in a bullish, low-volume flag.  On Monday the stock popped 49 cents,"},{"title":"Advaxis to Participate in Cervivor School","publication_date":"2016-08-19 12:11:06 +0000","url":"http://www.publicnow.com/view/EB57578F2CD7D02E8C9A7EA8216A2CF8896A5D48","summary":"[at noodls] - Kim Dorney to give opening keynote to cervical cancer survivors PRINCETON, N.J., Aug. 19, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS) a clinical-stage biotechnology company developing cancer immunotherapies, ..."},{"title":"Advaxis to Participate in Cervivor School","publication_date":"2016-08-19 12:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-participate-cervivor-school-120000855.html","summary":"[GlobeNewswire] - Kim Dorney to give opening keynote to cervical cancer survivors. ﻿PRINCETON, N.J., Aug. 19, 2016-- Advaxis, Inc. a clinical-stage biotechnology company developing cancer immunotherapies, is pleased to ..."},{"title":"ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial Con","publication_date":"2016-08-16 20:32:17 +0000","url":"http://biz.yahoo.com/e/160816/adxs8-k.html","summary":"ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial Con"},{"title":"Health Care Sector Update for 08/16/2016: ADXS,STEM,OGXI","publication_date":"2016-08-16 20:32:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OW7wwF5mijw/health-care-sector-update-for-08162016-adxsstemogxi-cm666193","summary":"Top Health Care Stocks JNJ 1.46% PFE 0.82% MRK 0.28% ABT 0.12% AMGN 1.06% Health care stocks fell Tuesday, with the NYSE Health Care Index today posting a 0.6% retreat while shares of health care companies in the S&P"},{"title":"Advaxis Secures a $30M Direct Placement Financing to Healthcare Specialist Investors","publication_date":"2016-08-16 13:41:06 +0000","url":"http://www.publicnow.com/view/A2075769922EC47000077C46AE9F3509249D6718","summary":"[at noodls] - PRINCETON, N.J., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced that it has entered into a definitive ..."},{"title":"Advaxis Secures a $30M Direct Placement Financing to Healthcare Specialist Investors","publication_date":"2016-08-16 13:32:11 +0000","url":"http://finance.yahoo.com/news/advaxis-secures-30m-direct-placement-133211895.html","summary":"[GlobeNewswire] - PRINCETON, N.J., Aug. 16, 2016-- Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, today announced that it has entered into a definitive securities purchase agreement ..."},{"title":"Advaxis Announces that Phase 2 Head and Neck Cancer Study with AXAL Advances to Second Stage","publication_date":"2016-08-11 12:11:05 +0000","url":"http://www.publicnow.com/view/9F65BF449558B1354948E0822E7227CF2FBF9FD9","summary":"[at noodls] - AXAL meets stage 1 primary objective, demonstrates increased systemic HPV-reactive T-cell responses PRINCETON, N.J., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology ..."},{"title":"How this trader improved","publication_date":"2016-08-04 14:06:04 +0000","url":"http://finance.yahoo.com/tumblr/blog-how-this-trader-improved-140609386.html","summary":"How this trader improved"},{"title":"Why Advaxis, Inc. Shares Are Soaring 11% Again Today","publication_date":"2016-08-03 17:56:32 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cYd9N7cn71o/why-advaxis-inc-shares-are-soaring-11-again-today-cm659809","summary":"Image source Getty Images. What After reporting a new collaboration with Amgen, Inc .(NASDAQ AMGN) on Wednesday, shares in Advaxis, Inc. (NASDAQ ADXS) continue to march higher today, gaining 11%"},{"title":"RIGL Awaits Key Data This Month, GeoVax Gets Funding, ADXS Jumps On Amgen Deal","publication_date":"2016-08-03 00:52:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TG5rUh0IRkE/rigl-awaits-key-data-this-month-geovax-gets-funding-adxs-jumps-on-amgen-deal-20160803-00008","summary":"RIGL Awaits Key Data This Month, GeoVax Gets Funding, ADXS Jumps On Amgen Deal"},{"title":"Why Advaxis Shares Could More Than Double, Even After the Amgen Deal","publication_date":"2016-08-02 16:35:07 +0000","url":"http://247wallst.com/healthcare-business/2016/08/02/why-advaxis-shares-could-more-than-double-even-after-the-amgen-deal/","summary":"Why Advaxis Shares Could More Than Double, Even After the Amgen Deal"},{"title":"Amgen, Regeneron Forge New, Separate Cancer Immunotherapy Pacts","publication_date":"2016-08-02 14:21:00 +0000","url":"https://www.thestreet.com/story/13661262/1/amgen-regeneron-forge-new-and-separate-cancer-immunotherapy-pacts.html?puc=yahoo&cm_ven=YAHOO","summary":"Amgen, Regeneron Forge New, Separate Cancer Immunotherapy Pacts"},{"title":"Advaxis stock jumps 28% on Amgen immunotherapy agreement","publication_date":"2016-08-02 12:42:41 +0000","url":"http://www.marketwatch.com/News/Story/Story.aspx?guid=6057D3BF-C3A9-4C87-AC0E-B12D9AB75760&siteid=yhoof2","summary":"Advaxis stock jumps 28% on Amgen immunotherapy agreement"},{"title":"ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and","publication_date":"2016-08-02 12:31:59 +0000","url":"http://biz.yahoo.com/e/160802/adxs8-k.html","summary":"ADVAXIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and"},{"title":"Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration","publication_date":"2016-08-02 12:31:11 +0000","url":"http://www.publicnow.com/view/78DA7A10CEA7957BA485FB99ECED4667F40AF707","summary":"[at noodls] - THOUSAND OAKS, Calif. and PRINCETON, N.J., Aug. 2, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Advaxis, Inc. (NASDAQ:ADXS) today announced a global agreement for the development and commercialization ..."},{"title":"Advaxis Shares Higher on Collaboration Deal With Amgen","publication_date":"2016-08-02 10:13:00 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LKwdwxRWjng/advaxis-shares-higher-on-collaboration-deal-with-amgen-20160802-00861","summary":"Advaxis Shares Higher on Collaboration Deal With Amgen"},{"title":"Phase 1/2 Combination Trial of AXAL and Durvalumab Completes Second Dose-Escalation Cohort","publication_date":"2016-07-26 12:00:00 +0000","url":"http://finance.yahoo.com/news/phase-1-2-combination-trial-120000742.html","summary":"[GlobeNewswire] - Part A expansion and Part B now enrolling for AXAL in combination with durvalumab for the treatment of advanced, recurrent or refractory HPV-associated cervical cancer and head & neck cancer. PRINCETON, ..."},{"title":"ADVAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits","publication_date":"2016-07-22 11:31:26 +0000","url":"http://biz.yahoo.com/e/160722/adxs8-k.html","summary":"ADVAXIS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits"},{"title":"Advaxis’ AXAL Receives Fast Track Designation by the FDA as Adjuvant Therapy for High-Risk Locally Advanced Cervical Cancer Patients","publication_date":"2016-07-21 11:00:00 +0000","url":"http://finance.yahoo.com/news/advaxis-axal-receives-fast-track-110000723.html","summary":"[GlobeNewswire] - PRINCETON, N.J., July 21, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that the U.S. Food and Drug Administration has designated the Company’ ..."},{"title":"Coverage Initiated on Select Biotech Stocks","publication_date":"2016-07-18 13:48:06 +0000","url":"http://news.investornetwork.com/2016/07/18/coverage-initiated-on-select-biotech-stocks-4/?1=1&1468849686","summary":"Coverage Initiated on Select Biotech Stocks"},{"title":"European Medicines Agency Committee Classifies Advaxis’ Axalimogene Filolisbac as an Advanced-Therapy Medicinal Product","publication_date":"2016-07-18 11:30:00 +0000","url":"http://finance.yahoo.com/news/european-medicines-agency-committee-classifies-113000422.html","summary":"[GlobeNewswire] - PRINCETON, N.J., July 18, 2016-- Advaxis, Inc., a clinical stage biotechnology company developing cancer immunotherapies, today announced that its lead Lm immunotherapy candidate, axalimogene filolisbac, ..."},{"title":"Is Advaxis' Stock Now a Bargain?","publication_date":"2016-07-15 15:13:08 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pzczBzVIGaw/is-advaxis-stock-now-a-bargain-cm649730","summary":"Image source Getty Images.. What  Shares of Advaxis (NASDAQ ADXS) , a clinical stage immunotherapy company, dropped by more than 14% last month, according to data from S&P Global Market Intelligence"},{"title":"Is Advaxis' Stock Now a Bargain?","publication_date":"2016-07-15 13:27:00 +0000","url":"http://www.fool.com/investing/2016/07/15/is-advaxis-stock-now-a-bargain.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2","summary":"Is Advaxis' Stock Now a Bargain?"},{"title":"Advaxis Appoints Ranya Dajani as Vice President, Corporate Development","publication_date":"2016-07-12 12:13:04 +0000","url":"http://www.publicnow.com/view/59EB6AD612B5CBA795B3F0A690E7F0784304A59C","summary":"[at noodls] - PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today announced Ranya Dajani joined Advaxis as ..."},{"title":"Advaxis to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference","publication_date":"2016-07-08 12:21:03 +0000","url":"http://www.publicnow.com/view/7C3F170A203BE1DD731480959B0C950B3863FE96","summary":"[at noodls] - PRINCETON, N.J., July 08, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O'Connor, President, ..."},{"title":"FDA Grants Special Protocol Assessment to Advaxis’ Phase 3 Study of AXAL in Patients with Cervical Cancer","publication_date":"2016-07-06 11:21:07 +0000","url":"http://www.publicnow.com/view/ADDEDDB3D69AA947EA6CA5B50C745367571B8CA7","summary":"[at noodls] - Enrollment to commence this summer PRINCETON, N.J., July 06, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced ..."},{"title":"Advaxis to Webcast Investor & Analyst Day 2016","publication_date":"2016-06-27 12:21:08 +0000","url":"http://www.publicnow.com/view/FDCAFE926117C95FB9B1DF26B4E6DFDC14590915","summary":"[at noodls] - PRINCETON, N.J., June 27, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that their annual Investor & Analyst ..."},{"title":"Why Advaxis, Inc. Stock Rose 19.6% in May","publication_date":"2016-06-09 15:16:29 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bqSXwUjehx0/why-advaxis-inc-stock-rose-196-in-may-cm632855","summary":"Image source Getty Images. What Shares of Advaxis, Inc. (NASDAQ ADXS) , a clinical stage biotech company developing cancer immunotherapies, rose 19.6% last month, according to data from S&P Global Market"},{"title":"Why Advaxis, Inc. Stock Rose 19.6% in May","publication_date":"2016-06-09 13:53:00 +0000","url":"http://www.fool.com/investing/2016/06/09/why-advaxis-inc-stock-rose-196-in-may.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2","summary":"Why Advaxis, Inc. Stock Rose 19.6% in May"},{"title":"Advaxis reports 2Q loss","publication_date":"2016-06-08 14:40:24 +0000","url":"http://sg.finance.yahoo.com/news/advaxis-reports-2q-loss-144024748.html","summary":"Advaxis reports 2Q loss"},{"title":"Advaxis Announces First Patient Dosed in Phase 2 Trial Evaluating AXAL in Anal Cancer","publication_date":"2016-06-08 12:08:04 +0000","url":"http://www.publicnow.com/view/DD4D411F503177445A9EBD350DEE618924F31E9F","summary":"[at noodls] - FAWCETT study named to honor Farrah Fawcett, who passed away from HPV-associated anal cancer PRINCETON, N.J., June 08, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology ..."},{"title":"Advaxis Announces Updated Data at ASCO from a Phase 2 Study of AXAL in Advanced Cervical Cancer Showing Promising Survival Rates Consistent with Earlier Reports","publication_date":"2016-06-06 11:18:06 +0000","url":"http://www.publicnow.com/view/461E27BE7A9443E7321FD5475242837A6D9EC704","summary":"[at noodls] - Durable complete response seen in a recurrent / metastatic cervical cancer patient previously treated with chemoradiation and systemic-dose chemotherapy plus bevacizumab PRINCETON, N.J., June 06, 2016 ..."},{"title":"Advaxis to Host Investor & Analyst Day on June 28, 2016","publication_date":"2016-05-17 12:42:05 +0000","url":"http://www.publicnow.com/view/D56855BBF3A2FEB19B74ED889592E5AC986ED6F4","summary":"[at noodls] - PRINCETON, N.J., May 17, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that they will host their annual ..."},{"title":"UPDATE – Advaxis to Present at Jefferies 2016 Healthcare Conference","publication_date":"2016-05-05 13:41:03 +0000","url":"http://www.publicnow.com/view/C74531CB2F64FF8D454F3B9B4A00D5286743502F","summary":"[at noodls] - PRINCETON, N.J., May 05, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O'Connor, President, ..."},{"title":"Advaxis to Present at Jeffries 2016 Healthcare Conference","publication_date":"2016-05-05 12:41:05 +0000","url":"http://www.publicnow.com/view/27B3025C9A88A01589C0C200196D939A510D0642","summary":"[at noodls] - PRINCETON, N.J., May 05, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O'Connor, President, ..."},{"title":"Health Care Sector Update for 04/28/2016: ADXS,ANIK,NVDQ","publication_date":"2016-04-28 18:19:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zw6gb3dqQ5E/health-care-sector-update-for-04282016-adxsaniknvdq-cm613323","summary":"Top Health Care Stocks JNJ 0.11% PFE +0.32% MRK 5.83% ABT 0.54% AMGN +1.13% Health care stocks have turned higher again this afternoon, with the NYSE Health Care Index climbing 0.1% while shares of health care companies in the"},{"title":"FDA Grants Advaxis Fast Track Designation for ADXS-HER2 for Patients with Newly-Diagnosed, Non-Metastatic, Surgically-Resectable Osteosarcoma","publication_date":"2016-04-28 11:22:12 +0000","url":"http://www.publicnow.com/view/C68C489862B550586AEDCC624484008C859AE6BE","summary":"[at noodls] - PRINCETON, N.J., April 28, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that the Food and Drug Administration ..."},{"title":"Phase II Cervical Cancer Study with Advaxis’ Axalimogene Filolisbac Selected for Poster Discussion Session at the 2016 ASCO Annual Meeting","publication_date":"2016-04-25 12:29:34 +0000","url":"http://www.publicnow.com/view/19909A2A67E654BE2B613307E1352E0E62DAF8B0","summary":"[at noodls] - Poster Discussion Sessions highlight the most clinically applicable and novel posters PRINCETON, N.J., April 25, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company ..."},{"title":"Notable Thursday Option Activity: RGLD, ADXS, FDS","publication_date":"2016-04-21 21:24:33 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B3RV2_VadyM/notable-thursday-option-activity-rgld-adxs-fds-cm609798","summary":"Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Royal Gold, Inc. (Symbol RGLD), where a total of 4,623 contracts have traded so far, representing approximately 462,300 underlying shares. That amounts"},{"title":"AACR Research Reception Featured Late-Breaking Poster on Lm Technology™ Platform","publication_date":"2016-04-19 13:15:04 +0000","url":"http://www.publicnow.com/view/7297FD4FD45A0CCFCC747E7E056B99D99BBC45B2","summary":"[at noodls] - Reception included update on the Company's MINE program (My Immunotherapy Neo-Epitopes) /ADXS-NEO immunotherapy STING Pathway and Advaxis' Lm Technology™ highlighted Slides and audio are available online ..."},{"title":"Late Breaking Data at AACR Annual Meeting from Advaxis Phase 2 Study of AXAL Highlights Potential of the Company’s Lm Technology™ Platform","publication_date":"2016-04-18 11:21:26 +0000","url":"http://www.publicnow.com/view/CC517E7F760064BA412C81180459C21668DDFB11","summary":"[at noodls] - First clinical data with AXAL to show evidence of cytotoxic T cell infiltration into the tumor immune microenvironment or TME for HPV-Positive oropharyngeal cancer PRINCETON, N.J., April 18, 2016 (GLOBE ..."},{"title":"Sarcoma Foundation of America Honors Advaxis for Advancements in Immunotherapy Platform","publication_date":"2016-04-13 12:24:14 +0000","url":"http://www.publicnow.com/view/2C71FBD3E10718314251884D547C5193A508A30E","summary":"[at noodls] - First biotechnology company to ever receive Vision of Hope Award PRINCETON, N.J., April 13, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer ..."},{"title":"Here's Why Advaxis Inc.'s Stock Roared Higher in March","publication_date":"2016-04-12 22:01:23 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HgjTiBHOzE0/heres-why-advaxis-incs-stock-roared-higher-in-march-cm605459","summary":"What Shares of the clinical state biotech Advaxis gained over 50% last month, according to data from S&P Global Market Intelligence . The main catalyst behind this monstrous surge was the news"},{"title":"Advaxis Combination Trial with Merck Completes First Two Dose-Escalation Cohorts","publication_date":"2016-04-05 12:10:34 +0000","url":"http://www.publicnow.com/view/A4E73D637D6691DD5E04DDC620ADEF7146A03158","summary":"[at noodls] - Study Evaluating ADXS-PSA Launches Third Dose-Escalation Cohort Part B Combination with 51 Patients to Begin Mid-Year PRINCETON, N.J., April 05, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a ..."},{"title":"Advaxis to Present at the 3rd Annual Jefferies Immuno-Oncology Summit","publication_date":"2016-04-04 13:27:09 +0000","url":"http://www.publicnow.com/view/BFF982354BB0FC2811264CEE94550A40DB203C33","summary":"[at noodls] - PRINCETON, N.J., April 04, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, will present at the 3rd Annual Jefferies Immuno-Oncology ..."},{"title":"Advaxis Combination Trial with MedImmune Completes First Dose-Escalation Cohort","publication_date":"2016-03-29 11:13:26 +0000","url":"http://www.publicnow.com/view/EE45B504CA8FC819847D6B6515E6E4815E04F243","summary":"[at noodls] - Study Commences Second Dose-Escalation Cohort 90-Patient Phase II Combination Trial in Cervical and Head and Neck Cancer to Begin Mid-Year PRINCETON, N.J., March 29, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. ..."},{"title":"Health Care Sector Update for 03/21/2016: OVAS,ADXS,CBMX","publication_date":"2016-03-21 20:26:54 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qi_ntjcQJAM/health-care-sector-update-for-03212016-ovasadxscbmx-cm596021","summary":"Top Health Care Stocks JNJ 0.23% PZE +2.14% MRK 0.13% ABT +1.01% AMGN +1.04% Health care stocks Monday rose for the first time in three sessions, with the NYSE Health Care Index climbing about 0.1% while shares of health"},{"title":"Why Advaxis, Inc. Shares Are Soaring 16% Today","publication_date":"2016-03-21 20:16:45 +0000","url":null,"summary":"SOURCE ADVAXIS, INC. What After reporting intriguing data for its cancer therapy in dogs that could have implications for human cancer patients, shares in Advaxis, are rallying 15% at 2"},{"title":"Why Advaxis, Inc. Shares Are Soaring 16% Today","publication_date":"2016-03-21 20:16:45 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M4p9HSaSRXg/why-advaxis-inc-shares-are-soaring-16-today-cm595974","summary":"SOURCE ADVAXIS, INC. What After reporting intriguing data for its cancer therapy in dogs that could have implications for human cancer patients, shares in Advaxis, are rallying 15% at 2"},{"title":"Monday's ETF Movers: XBI, ITB","publication_date":"2016-03-21 20:10:27 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5cSs8xOO_10/mondays-etf-movers-xbi-itb-cm595983","summary":"In trading on Monday, the SPDR S&P Biotech ETF ( XBI ) is outperforming other ETFs, up about 2.8% on the day. Components of that ETF showing particular strength include shares of Sarepta Therapeutics ( SRPT ), up about"},{"title":"Health Care Sector Update for 03/21/2016: AFFX,TMO,ADXS,CBMX","publication_date":"2016-03-21 18:46:55 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JVG6E297AsI/health-care-sector-update-for-03212016-affxtmoadxscbmx-cm595959","summary":"Top Health Care Stocks JNJ 0.11% PZE +1.82% MRK 0.32% ABT +0.88% AMGN +1.53% Health care stocks Monday were narrowly rising for the first time in three sessions, with the NYSE Health Care Index climbing about 0.1% while shares"},{"title":"Wednesday's ETF Movers: XBI, MTUM","publication_date":"2016-03-02 20:35:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UtVjTPtyUvU/wednesdays-etf-movers-xbi-mtum-cm587463","summary":"In trading on Wednesday, the SPDR S&P Biotech ETF ( XBI ) is outperforming other ETFs, up about 3.1% on the day. Components of that ETF showing particular strength include shares of Advaxis ( ADXS ), up about 24.9%"},{"title":"Why Advaxis Gained 20% in 2015","publication_date":"2016-01-14 14:17:26 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CL5bUfn2toM/why-advaxis-gained-20-in-2015-cm565642","summary":"What According to S&P Capital IQ , the clinical stage cancer immunotherapy company Advaxis gained almost 20% last year. The stock's rise was due to the growing excitement over cancer immunotherapies in"},{"title":"Why Advaxis, Inc Shares are Skyrocketing Today","publication_date":"2015-12-16 19:14:56 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NecpRdF5tb8/why-advaxis-inc-shares-are-skyrocketing-today-cm555597","summary":"What  Shares of Advaxis , a clinical stage biotechnology company focused on cancer immunotherapy, were trading more than 29% higher as of 12 00 p.m. EST after news broke that the FDA has"},{"title":"Here's Why Advaxis' Stock Gained 11% in October","publication_date":"2015-11-17 18:14:10 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bFqb2VwT9Co/heres-why-advaxis-stock-gained-11-in-october-cm544131","summary":"What Advaxis , a clinical stage cancer immunotherapy company, saw its shares gain over 11% in October, according to data provided by S&P Capital IQ . Even so, the company didn't"},{"title":"Noteworthy Monday Option Activity: ADXS, AKRX, CIEN","publication_date":"2015-11-16 21:00:52 +0000","url":"http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/otdwDHSoF3U/noteworthy-monday-option-activity-adxs-akrx-cien-cm543698","summary":"Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Advaxis, Inc. (Symbol ADXS), where a total of 6,748 contracts have traded so far, representing approximately 674,800 underlying shares. That amounts to"},{"title":"Texas Instruments tipped as chip industry's next consolidator","publication_date":"2015-06-19 20:25:43 +0000","url":"http://sg.finance.yahoo.com/news/texas-instruments-tipped-chip-industrys-202543504.html","summary":"Texas Instruments tipped as chip industry's next consolidator"}],"result_count":119,"page_size":250,"current_page":1,"total_pages":1,"api_call_credits":1}},
{"id":"2","list":"Pre Market Movers","symbol": "TELL","name": "Tellurian Inc. - Com","price": 10.1,"dollarChange": 0.230000,"percentChange": 2.330294,"time":4.0,"oneDayNull":"0","oneDay": "http://automatedinvestmentresearch.com/TELL-1d.php","oneMonth": "http://automatedinvestmentresearch.com/TELL-1mo.php","threeMonthNull":"0","threeMonth": "http://automatedinvestmentresearch.com/TELL-3mo.php","sixMonthNull":"0","sixMonth": "http://automatedinvestmentresearch.com/TELL-6mo.php","oneYearNull":"0","oneYear": "http://automatedinvestmentresearch.com/TELL-1yr.php","open": 11.2,"high": 11.68,"low":9.69,"volume": 2525434,"avgVol": 518109.533333,"sharesShort": 0,"shortPercent": 0.000000,"marketCap": 3560979451,"float": 199382948,"headlines":{"data":[],"result_count":0,"page_size":250,"current_page":1,"total_pages":0,"api_call_credits":1}}
]
